JPRN-UMIN000001700
Completed
Phase 3
A randomized, multicenter, controlled trial of the effectiveness of nebulized therapy with 3% hypertonic saline solution compared with 0.9% saline solution in hospitalized infants with RS viral bronchiolitis. - Nebulized 3% hypertonic saline solution treatment in hospitalized infants with RS viral bronchiolitis.
Tokyo Metropolitan Children's medical center Hospital0 sites120 target enrollmentFebruary 10, 2009
ConditionsRS viral bronchiolitis
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- RS viral bronchiolitis
- Sponsor
- Tokyo Metropolitan Children's medical center Hospital
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)pCO2 is more than 60 mm Hg by venous blood gas or SpO2 is under 95 % under administration of oxygen. 2\)diagnosed episode of wheezing previously. 3\)Cerebral palsy, congenital heart desease, lung disease, muscular disorder, malformed syndrome, immune deficiency disorder 4\)a patient who was born by premature birth equal to or less than several a week 35 weeks for gestational ages 5\)a patients administrated palivizumab. 6\)a patients with apnea 7\)Judged a patients needed intubation by the physicians. 8\)Judged inappropriate for this study by the physicians.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The clinical and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shockSevere sepsis/septic shockInfections and InfestationsOther septicaemiaISRCTN36307479Intensive Care National Audit and Research Centre (ICNARC) (UK)1,260
Recruiting
Phase 3
Australasian Resuscitation In Sepsis Evaluation Randomised Controlled TrialACTRN12608000053325Australian and New Zealand Intensive Care Research Centre1,600
Not yet recruiting
Phase 1
A multicenter, randomized, controlled trial for a novel vaginal microecologic therapy for the treatment of persistent cervical human papillomavirus infection at high riskITMCTR2000003652Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Recruiting
Phase 1
A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategysevere novel coronavirus pneumonia (COVID-19)ITMCTR2000003002Huangshi Hospital of Traditional Chinese Medicine
Not yet recruiting
Phase 4
A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategyITMCTR2000003019Huangshi Hospital of Traditional Chinese Medicine